ロード中...
RNAi targeting heparin cofactor II promotes hemostasis in hemophilia A
Hemophilia A is a hemorrhagic disease due to congenital deficiencies of coagulation factor VIII (FVIII). Studies show that hemophilia patients with anticoagulant deficiency present less severe hemorrhagic phenotypes. We aimed to find a new therapeutic option for hemophilia patients by RNA interferen...
保存先:
| 出版年: | Mol Ther Nucleic Acids |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Gene & Cell Therapy
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8093307/ https://ncbi.nlm.nih.gov/pubmed/33996250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2021.03.022 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|